Ignite Creation Date:
2024-05-05 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002223
Status:
COMPLETED
Last Update Posted:
2009-02-20
First Post:
1999-11-02
Brief Title:
A Study of RitonavirIndinavir Combination in HIV-Infected Patients
Sponsor:
Abbott
Organization:
Abbott
Study Overview
Official Title:
Ritonavir ABT-538Indinavir Combination Treatment in HIV-Infected Patients Previously Receiving Indinavir 800 mg TID
Status:
COMPLETED
Status Verified Date:
2009-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to determine how many HIV-infected patients continue taking ritonavirindinavir combination after having taken indinavir three times a day as part of their anti-HIV drug therapy This study also examines the safety and effectiveness of the ritonavirindinavir combination
Detailed Description:
None
Study Oversight
Has Oversight DMC:
Is a FDA Regulated Drug?:
Is a FDA Regulated Device?:
Is an Unapproved Device?:
Is a PPSD?:
Is a US Export?:
Is an FDA AA801 Violation?:
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| M98-823 | None | None | None |